Clinical trial
Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5%…
NCT00441415 · Galderma R&D, Industry · Completed
Key facts
| NCT number | NCT00441415 |
|---|---|
| Title | Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris |
| Official title | Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel Compared to Clindamycin 0.1% / Benzoyl Peroxide 5% Gel in the Treatment of Acne Vulgaris |
| Lead sponsor | Galderma R&D, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acne Vulgaris |
| Intervention type | Drug |
| Interventions | Adapalene BPO |
| Enrollment | 272 |
| Start date | Feb 1, 2007 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Feb 28, 2007 |
| Last update posted | Feb 17, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: